Tilmicosin for Goat: Uses, Risks & Why Vets Are Cautious

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Tilmicosin is a macrolide antibiotic related to tylosin. In the U.S., the injectable product most people recognize is Micotil 300, which is FDA-labeled for certain respiratory disease uses in cattle and sheep, not goats. That matters because goats are food animals, and using tilmicosin in a goat is generally an extra-label decision that must come from your vet within a valid veterinarian-client-patient relationship.

Your vet may be cautious with tilmicosin for two big reasons. First, it has a serious human safety risk. Accidental self-injection can cause severe heart effects and has been associated with death, even with small amounts. Second, goats appear to be more vulnerable to toxic effects than the labeled species, and deaths after exposure have been reported to FDA in goats.

Tilmicosin also stays concentrated in lung tissue for a relatively long time, which is why it has been considered for respiratory infections. But that same potency is part of why handling, route, dose, and withdrawal planning need careful veterinary oversight. This is not a medication pet parents should keep and use casually.

When your vet considers tilmicosin in a goat, it is usually because they are trying to treat a suspected bacterial respiratory infection, especially pneumonia involving organisms such as Mannheimia haemolytica or Pasteurella multocida. Merck notes tilmicosin as a macrolide that can be used for respiratory disease in small ruminants, but also highlights the major human exposure risk and the fact that the sheep label does not extend to goats.

In real-world goat medicine, your vet may compare tilmicosin with other antibiotics that are often easier to handle or have a more familiar safety profile in goats. Culture, herd history, severity of illness, pregnancy or lactation status, and whether the goat may enter the food chain all affect that decision.

Tilmicosin is not a routine first-choice medication for every coughing goat. Pneumonia can be caused by bacteria, viruses, parasites, aspiration, stress, or mixed infections. Because of that, your vet may recommend an exam, temperature check, lung assessment, and sometimes testing before deciding whether any antibiotic, including tilmicosin, makes sense.

Do not dose tilmicosin in a goat without direct instructions from your vet. In the U.S., the labeled sheep dose for Micotil 300 is a single subcutaneous injection of 10 mg/kg, which equals about 1 mL per 30 kg body weight. That labeled sheep information is sometimes used as a reference point, but goats are not a labeled species, so your vet must decide whether extra-label use is appropriate and legal for that specific animal.

Route matters. Tilmicosin is intended for subcutaneous use only in labeled species. Intravenous administration is fatal in cattle and sheep, and route errors can be catastrophic. Because this drug can also be dangerous to the person giving it, many veterinarians prefer to administer it themselves or choose a different antibiotic altogether.

For food-producing goats, dosing is only part of the conversation. Your vet also has to determine a meat and milk withdrawal plan that avoids violative residues. Under U.S. extra-label rules, that means veterinary oversight, treatment records, and withdrawal guidance tailored to the animal's use. If your goat produces milk or may eventually enter the food chain, tell your vet before any dose is given.

The biggest concern with tilmicosin is cardiotoxicity. Toxic effects are linked to increased heart rate and reduced heart contractility, and this appears related to calcium-channel effects on the heart. In goats, reported problems after exposure have included collapse and death. That is one reason many veterinarians are very selective about whether they use this drug at all in goats.

Possible animal side effects can include weakness, rapid breathing, distress, collapse, poor appetite, injection-site swelling, and sudden death. If your goat seems worse after treatment, acts weak, lies down and will not rise, breathes hard, or shows a racing heartbeat, see your vet immediately.

There is also a major human safety emergency attached to this medication. Accidental injection, skin exposure, eye exposure, or swallowing the drug can be dangerous. If a person is exposed, seek emergency medical help right away and bring the product label or package information. This is one of the clearest reasons pet parents should never use leftover tilmicosin without veterinary direction and proper safety equipment.

Published goat-specific interaction data are limited, so your vet will usually take a cautious approach. Because tilmicosin can affect the heart, your vet may be especially careful if a goat is already receiving medications that can change heart rate, rhythm, blood pressure, or cardiac contractility.

That caution can extend to drugs with cardiac depressant effects or medications used around emergencies and anesthesia. In toxicology discussions of tilmicosin exposure, cardiovascular support choices matter, which is another reason this drug should only be used where your vet can evaluate the full medication list and the goat's overall condition.

It is also wise to tell your vet about every product your goat has received recently, including dewormers, anti-inflammatories, mineral drenches, supplements, and any over-the-counter farm products. In food animals, interaction concerns are not only about safety. They can also affect treatment response, residue planning, and withdrawal timing.